Chemidarou

Chemidarou is a prominent Iranian pharmaceutical company originally established in 1965 as a subsidiary of the German firm Hoechst. The company specializes in the development, manufacturing, and distribution of a wide range of finished dosage forms, including tablets, capsules, and oral liquids. Its product portfolio covers diverse therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, and metabolic diseases. Chemidarou operates modern manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards and is a major supplier to the domestic Iranian healthcare market. The company is publicly traded on the Tehran Stock Exchange and is part of the Tamin Pharmaceutical Investment Company (TPICO) group.